![Jason Fontenot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Fontenot
Nessuna posizione attualmente
Profilo
Jason D.
Fontenot served as the Chief Scientific Officer & Senior Vice President at Sangamo Therapeutics, Inc. from 2021 to 2024.
Prior to that, he was the Chief Scientific Officer at Immusoft Corp.
from 2018 to 2019.
Before joining Immusoft Corp., he worked as the Head-Exploratory Research at Juno Therapeutics, Inc. from 2016 to 2018.
Mr. Fontenot holds a doctorate degree from the University of Washington.
Precedenti posizioni note di Jason Fontenot
| Società | Posizione | Fine |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 02/01/2024 |
Immusoft Corp.
 Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells | Direttore Tecnico/Scientifico/R&S | 01/03/2019 |
| JUNO THERAPEUTICS INC | Direttore Tecnico/Scientifico/R&S | 01/01/2018 |
Formazione di Jason Fontenot
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
22
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells | Health Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
